March 11, 2020 / 11:31 AM / a month ago

BRIEF-Parallax Diagnostics Says Intent To Develop Rapid Screening Test For Covid-19

March 11 (Reuters) - Parallax Health Sciences Inc:

* PARALLAX DIAGNOSTICS ANNOUNCES INTENT TO DEVELOP A RAPID SCREENING TEST FOR COVID-19 ON ITS PATENTED FDA 510(K) APPROVED DIAGNOSTIC PLATFORM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below